<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/ECF22327-6842-49CB-A398-31B6AAD9B89A"><gtr:id>ECF22327-6842-49CB-A398-31B6AAD9B89A</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Tobin</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_A600_1110"><gtr:id>9DDCE866-D999-4D2C-BEAC-EB92F55B24FF</gtr:id><gtr:title>Physiological role of G-protein coupled receptors and models that investigate in vivo modes of action and toxicity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_A600_1110</gtr:grantReference><gtr:abstractText>Humans are made up of literally billions of individual cells. These cells group together to make familiar organs such as lungs, heart, liver, kidneys and the brain. In order for these cells to function they have to communicate with each other. To do this cells in our body release chemicals that act as messengers ? chemical messengers. These chemical messengers can be released in to the blood, for example, where they are transported to the ?target? cells. The target cells have special proteins on the surface that are able to bind to very specifically to the chemical messengers. These proteins are called receptors. When the chemical messenger binds to a receptor it causes the target cell to respond. For example, if this were a heart cell and the chemical messenger was adrenaline then the heart cell would respond by beating faster and harder. The study described here will investigate this process of chemical stimulation of receptors. We will use new animal models to work out how animal?s respond when receptors are stimulated and how we might make better drugs that target these receptors.</gtr:abstractText><gtr:technicalSummary>The G-protein coupled receptors (GPCRs) represent one of the largest gene families in the human genome where receptors respond with exquisite selectivity to a plethora of natural ligands to regulate nearly every mammalian cellular process. This, coupled to the fact that it is possible to design small molecule activators (agonists) and inhibitors (antagonists) to GPCRs has meant that this class of receptor has been extensively targeted in therapeutic interventions for the treatment of numerous human diseases. It is now widely recognised that in order for GPCRs to reach their full potential as therapeutic targets a number of barriers have to be overcome. Prominent among these is the paucity of animal models that can reveal the biological function and therapeutic potential of selective GPCRs. This is linked with the need to define model systems that can test for the potential toxic outcomes of targeting GPCR subtypes. The current proposal aims to address these key areas by employing genetics and chemical genetics in combination with animal behavioural studies, proteomics, molecular pharmacology and biochemical evaluation of signal transduction we aim to develop animal models that will not only define the physiological role of GPCRs and determine the therapeutic potential of targeting a given GPCR subtype but that will also provide tools by which GPCR ligands can be tested for potential toxicity together with an experimental framework that will allow for the design of ligands that will bias receptor signalling away from pathways resulting in toxicity and towards pathways of therapeutic benefit. The primary model system adopted here are the receptors of the muscarinic receptor family that respond to the natural ligand acetylcholine. Of the 5 members of this family M1, M3 and M4-muscarinic subtypes have been linked to the control of airway smooth muscle contraction and airway hyper-responsiveness (M3), insulin release and glucose homeostasis (M3), and complex neurological responses including learning and memory (M1 and M3) and psychosis (M4). In this proposal we plan to exploit the broad array for cellular and physiological responses of the muscarinic receptor family together with the availability of an increasing battery of pharmacological tools to determine the physiological role of the M1, M3, and M4-muscarinic receptors and determination of the in vivo modes of action and potential toxic outcomes of novel pharmacological entities that target these receptors.</gtr:technicalSummary><gtr:fund><gtr:end>2016-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>4251634</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Meeting at Astra Zeneca (Sweden Sept 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>409D635B-D4AC-4216-BD68-EBDCA1F9578F</gtr:id><gtr:impact>Meeting at AZ to 80 people

Set up industrial grant collaboration</gtr:impact><gtr:outcomeId>Jc4hZfjexJy</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keystone Meeting: G Protein-Coupled Receptors: Structural Dynamics and Functional Implications. Utah USA. April 2014.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C4A6E9D2-6103-46CF-9A9B-A84435E29193</gtr:id><gtr:impact>Research meeting

Keystone Meeting: G Protein-Coupled Receptors: Structural Dynamics and Functional Implications. Utah USA. April 2014.</gtr:impact><gtr:outcomeId>56e03120471a66.21332434</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GPCRs, from physiology to drugs. Rescuing memory loss in neurodegeneration. Toulouse, France 2015.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E0E1E1C5-D24A-4B0F-841C-D02DBB386037</gtr:id><gtr:impact>Research meeting:

GPCRs, from physiology to drugs. Rescuing memory loss in neurodegeneration. Toulouse, France 2015.</gtr:impact><gtr:outcomeId>56e02f3d5f7101.01530126</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MMV Talk Geneva (Sept 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F97AB9AA-27F4-4C15-8960-39EB3E80EB2F</gtr:id><gtr:impact>Talk presented to 20 people

Dissemination of research data</gtr:impact><gtr:outcomeId>HkWFgQXzzvQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Anglo Swedish Med Chem Meeting (June 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EFBF4685-09BC-41A5-8968-275A98B4A704</gtr:id><gtr:impact>Talk at research meeting to 70 people

Dissemination of research data</gtr:impact><gtr:outcomeId>kZXB9Uvy59k</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IUBMB-SBBq Meeting on Host-Pathogen Signaling. Drugging the malaria kinome. Igua?u Foz, Brazil. August 2015.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0A654ADA-633D-4B24-9857-0A80DEF50B81</gtr:id><gtr:impact>Research meeting in malaria</gtr:impact><gtr:outcomeId>56e02f7177c319.77204854</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference invitation:  Keystone Meeting: G Protein-Coupled Receptors: Structural Signalling and Drug Discovery. Colorado, USA. Feb 2016.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>198246B7-8AB3-4D62-9CF6-83F00783332F</gtr:id><gtr:impact>Keystone Meeting: G Protein-Coupled Receptors: Structural Signalling and Drug Discovery. Colorado, USA. Feb 2016.</gtr:impact><gtr:outcomeId>56e02eb24a1069.26692199</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public outreach - Science and religion - Leicester 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5F71ADEA-E53C-4181-8C46-B036108A6DB0</gtr:id><gtr:impact>Public outreach - Science and religion - Leicester 2016</gtr:impact><gtr:outcomeId>56e031c7d8bd60.86005956</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>8th International Conference on Inhibitors of Protein Kinases (IPK2014). Role of PfPKG in maintaining the malaria parasite. Warsaw, Poland. September 2014.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>988B7A33-540C-4B56-A441-C9AC23A11F56</gtr:id><gtr:impact>8th International Conference on Inhibitors of Protein Kinases (IPK2014). Role of PfPKG in maintaining the malaria parasite. Warsaw, Poland. September 2014.</gtr:impact><gtr:outcomeId>56e030bd219724.73079964</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Argentinian Society of Parasitology Meeting. Targeting the malarial kinome. Mar Del Plata, Argentina. November 2014.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>262456E3-3CB3-4105-9E9B-F17E21E0995D</gtr:id><gtr:impact>Research meeting

Argentinian Society of Parasitology Meeting. Targeting the malarial kinome. Mar Del Plata, Argentina. November 2014.</gtr:impact><gtr:outcomeId>56e030476e8538.09105166</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at GlaxoSmithKline, Durham , North Carolina, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3171D3C4-3E5D-42DC-B800-E259C74DB609</gtr:id><gtr:impact>Talk at GlaxoSmithKline, Durham , North Carolina, USA. To discuss malaria drug discovery programme

Important dissemination of drug discovery results and future planning</gtr:impact><gtr:outcomeId>BsRFXDVvJyL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Hawaiian GPCR workshop. Memory and learning in prion neurodegeneration. Big Island, Hawaii, USA. December 2015.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CCA08CA4-6BBD-4605-812B-28A15ED1AAD8</gtr:id><gtr:impact>Hawaiian GPCR workshop. Memory and learning in prion neurodegeneration. Big Island, Hawaii, USA. December 2015.</gtr:impact><gtr:outcomeId>56e02f02532e21.51258817</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at the Department of Pharmacology, UNC, Chapel Hill, NC USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ED50DC8A-646C-4B40-8F55-93BAF08A1434</gtr:id><gtr:impact>Talk to the Department of Pharmacology at UNC

Important dissemination of research resutls and building collaborations</gtr:impact><gtr:outcomeId>BUqCtEAa9JN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Experimental Biology Meeting -Boston  (2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5A0F70FC-EB3F-4EBF-AE4D-9DA7B5C806AA</gtr:id><gtr:impact>Over 600 scientist present

Very important collaborations and impact of my research</gtr:impact><gtr:outcomeId>cZ2AStiaZwc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GPCR Talk at Nottingham (Tony Birmingham Lecture)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3AD44FD4-D7D6-4CE3-BD6E-DBF0FF12C9E9</gtr:id><gtr:impact>Tony Birmingham Lecture to around 100 people

Dissemination of data</gtr:impact><gtr:outcomeId>mJHWjx9mQFf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release from Nature Communications paper: Television/radio and news papers as well as online journals</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1171C37F-BF4B-4587-8FFD-D8444992B1F9</gtr:id><gtr:impact>Press release from Nature Communications paper: Television/radio and news papers as well as online journals</gtr:impact><gtr:outcomeId>56e03251826f00.31273732</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Protein kinases of parasitic protozoa. Chemical genetic approaches to dissecting the malaria kinome. Haifa, Israel. March 2015.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>94E2F12C-BCE7-4329-8E7A-E7231A632CE4</gtr:id><gtr:impact>Research meeting;

Protein kinases of parasitic protozoa. Chemical genetic approaches to dissecting the malaria kinome. Haifa, Israel. March 2015.</gtr:impact><gtr:outcomeId>56e02fdc4144d6.06564018</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GPCR Talk (Warwick University) Feb 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>97481C2C-ED16-4816-9640-CA3699270A43</gtr:id><gtr:impact>Departmental Seminar to around 80 people

Dissemination of research data</gtr:impact><gtr:outcomeId>UuLWipeyGms</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Malaria Gordon Conference (2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>90A41746-E33C-4785-B14D-08F8A3443854</gtr:id><gtr:impact>Over 150 scientist attended meeting

Important collaborations and funding opportunities</gtr:impact><gtr:outcomeId>dLb94qobLcG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science and Ethics - Beauchamp College</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>06505E50-DAAE-4CEE-B4B7-66C914F4C6E9</gtr:id><gtr:impact>Spark discussions</gtr:impact><gtr:outcomeId>54639e81ebda86.96561185</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at the department of pharmacology at Vanderbilt. May 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>45066F68-16CE-4E6F-924E-F028E9B1AB13</gtr:id><gtr:impact>Talk at the department of pharmacology at Vanderbilt. May 2012</gtr:impact><gtr:outcomeId>B4JXb7H4m9r</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science School Visit - St johns primary school</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>37506081-9867-4066-A1B6-B08AB090416A</gtr:id><gtr:impact>Spark discussions</gtr:impact><gtr:outcomeId>54639dda4121b3.23530446</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - GCSE year - Beauchamp college</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>12F0EA40-28D3-499C-91BF-B86F5775FB6B</gtr:id><gtr:impact>Spark discussions</gtr:impact><gtr:outcomeId>54639e310d4d75.33138517</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science and Ethics - Leicester Grammar School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>797E6D41-59AD-4C12-ADD8-0B6CB7758309</gtr:id><gtr:impact>Science and Ethics - Leicester Grammar School</gtr:impact><gtr:outcomeId>54639f0ea52d27.13519189</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Bristol Myers Squibb New Jersey (April 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0F5181B1-7B08-4EDD-BCFF-32FDDC8A4BD2</gtr:id><gtr:impact>Talk at the company BMS - 60 people

Dissemination of research data</gtr:impact><gtr:outcomeId>aZnLsfZ1Zer</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit (Leicester)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CFE55A96-0D0B-4655-A73B-45AE1637E60F</gtr:id><gtr:impact>Demonstration to local primary school (35 pupils)

Important out-reach to a local school. Building relationship.</gtr:impact><gtr:outcomeId>hXH9W8TM4TK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Teaching at the University of Rome (June 2013)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F51DA2AB-3B7F-4622-AA6B-535E275958FB</gtr:id><gtr:impact>teaching malaria/GPCRs to 20 students

Teaching</gtr:impact><gtr:outcomeId>THP8hUiP3Rt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at the MRC Unit The Gambia (March 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>957DD207-17E0-443F-B6A9-823D79948BDC</gtr:id><gtr:impact>Talk on Malaria to around 50 people

Set U MRC Tox/MRC Gambia PhD student</gtr:impact><gtr:outcomeId>AB7GcVadWFP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Toxicology Unit</gtr:department><gtr:description>Evaluation of muscarinic receptor efficacy versus toxicity</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>FA45B850-8EB7-42FC-ADDF-2CAF2945646A</gtr:id><gtr:outcomeId>i5VAP3U4fpm</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE Studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>F4695CF7-B733-4C0A-A4A9-6877D78E2CCF</gtr:id><gtr:outcomeId>QXZC1nrmqrK</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Eli Lilly Academic/Industrial Collaboration (LIFT-Grant)</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Eli Lilly &amp; Company Ltd</gtr:fundingOrg><gtr:id>2684A18D-D43B-4118-9A1E-0FBA6B691B50</gtr:id><gtr:outcomeId>WrrKhFzzLb5</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GPR120: a G protein-coupled receptor with the potential to regulate insulin secretion and inflammation</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K019856/1</gtr:fundingRef><gtr:id>33FA0A6D-C06E-494D-9CEF-190EBA2B6C71</gtr:id><gtr:outcomeId>JcjXgco4Zh6</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The global phospho-proteomic data was deposited on the open access data base PLASMODB</gtr:description><gtr:id>1D7DA530-1EB1-40D2-A491-6F98BF0EB970</gtr:id><gtr:impact>This has made a significant impact on the malaria research community</gtr:impact><gtr:outcomeId>WMzZ3v2BtpC</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Deposited large proteomic data on PLASMODB</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:url>http://plasmodb.org/plasmo/</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have made a number of muscarinic receptor mouse models to test the efficacy of muscarinic receptor ligands in disease</gtr:description><gtr:id>6D1FBFBF-86A1-4EA1-A0C8-FC2ACE604337</gtr:id><gtr:impact>This has offered novel mouse models to the dementia field</gtr:impact><gtr:outcomeId>58c88bc3ad6351.55604004</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Muscarinic transgenic mice models</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The facility has allowed for new methods in mass spectrometry based phosphor-proteomics to have been developed</gtr:description><gtr:id>5EF79435-E6C8-483F-AB76-D3E798CD3061</gtr:id><gtr:impact>This has allowed for integration of both mammalian (hippocampal) and malaria phosphor-proteomes</gtr:impact><gtr:outcomeId>56e9151834ef88.16210083</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Novel proteomic approaches</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B3524575-47A7-444E-A066-A61835968120</gtr:id><gtr:title>Physiological role of G-protein coupled receptor phosphorylation.</gtr:title><gtr:parentPublicationTitle>Handbook of experimental pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e0c9a4fe0722e2c4d5cb352e985443"><gtr:id>36e0c9a4fe0722e2c4d5cb352e985443</gtr:id><gtr:otherNames>Butcher AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0171-2004</gtr:issn><gtr:outcomeId>pm_15219_29_22222696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7BF8608-992F-42A5-810B-6D897FEF89C1</gtr:id><gtr:title>Employing novel animal models in the design of clinically efficacious GPCR ligands.</gtr:title><gtr:parentPublicationTitle>Current opinion in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/655e2cbad5f6560f048d3541e90b0d96"><gtr:id>655e2cbad5f6560f048d3541e90b0d96</gtr:id><gtr:otherNames>Bradley SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0955-0674</gtr:issn><gtr:outcomeId>545cf4239d3ff3.82698494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEBF9AD1-DD03-4B58-B95B-FF4F8C356A58</gtr:id><gtr:title>Applying chemical genetic tools to the study of phospho-signalling pathways in malaria parasites.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00b5cf840fa8b4496e82b687a8370438"><gtr:id>00b5cf840fa8b4496e82b687a8370438</gtr:id><gtr:otherNames>Mitcheson DF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56e02ccf37f188.18391250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28C58DB3-55B8-4ADB-988B-A7F46CE4BCCF</gtr:id><gtr:title>Concomitant action of structural elements and receptor phosphorylation determines arrestin-3 interaction with the free fatty acid receptor FFA4.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e0c9a4fe0722e2c4d5cb352e985443"><gtr:id>36e0c9a4fe0722e2c4d5cb352e985443</gtr:id><gtr:otherNames>Butcher AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>545cf424539494.31941233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF171B57-33CE-49BC-B549-D41924C668B6</gtr:id><gtr:title>Experimental tools for the study of protein phosphorylation in Plasmodium.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41238ea5149dd318addaaa12235ff25f"><gtr:id>41238ea5149dd318addaaa12235ff25f</gtr:id><gtr:otherNames>Dorin-Semblat D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>doi_15219_3_026_7_16</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE5C2CA1-3DC0-429A-A6C0-AA848DEFCFDB</gtr:id><gtr:title>Post-translational protein modifications in malaria parasites.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/540040d1c1228e9d773fee073af0bb60"><gtr:id>540040d1c1228e9d773fee073af0bb60</gtr:id><gtr:otherNames>Doerig C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>56e02cf1dea705.53277167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F6072CA-0D99-4365-84B3-11B92989C7A5</gtr:id><gtr:title>Influence of the accessory protein SET on M3 muscarinic receptor phosphorylation and G protein coupling.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29c7ed2f56b3025c4a590c4410760a74"><gtr:id>29c7ed2f56b3025c4a590c4410760a74</gtr:id><gtr:otherNames>Simon V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>pm_15219_29_22466417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>359B9EA6-233B-4E9D-B8B6-86B1DDFB0A6D</gtr:id><gtr:title>Malaria protein kinase CK2 (PfCK2) shows novel mechanisms of regulation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b764675cfa48a9f75f8590c10bbbdd91"><gtr:id>b764675cfa48a9f75f8590c10bbbdd91</gtr:id><gtr:otherNames>Graciotti M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545cf42428e706.21819223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EDED353-19C8-4BC2-96B1-C34E5F02B5A1</gtr:id><gtr:title>The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fafa3eb19a78acaea232fe40c8087fe6"><gtr:id>fafa3eb19a78acaea232fe40c8087fe6</gtr:id><gtr:otherNames>Hudson BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>pm_15219_29_23979972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D2D0501-833A-4914-B1B9-9982EB2F89B8</gtr:id><gtr:title>The experimental power of FR900359 to study Gq-regulated biological processes.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba1df822e712110bf8f07f58b9a89cfe"><gtr:id>ba1df822e712110bf8f07f58b9a89cfe</gtr:id><gtr:otherNames>Schrage R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56e02b7bcc96f4.48566006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>045E1D32-F796-42CC-A853-DFD52CBE6C23</gtr:id><gtr:title>Engineered hyperphosphorylation of the ?2-adrenoceptor prolongs arrestin-3 binding and induces arrestin internalization.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f93c109d92d65d768622d0833a92afcb"><gtr:id>f93c109d92d65d768622d0833a92afcb</gtr:id><gtr:otherNames>Zindel D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>56e02b45580b75.65465406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D1B9C39-9D3D-411A-B189-5481B809C96E</gtr:id><gtr:title>CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5ee5a13f7d6b0787d4919dd19ba893a"><gtr:id>c5ee5a13f7d6b0787d4919dd19ba893a</gtr:id><gtr:otherNames>Rossi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56e02c12448a31.10861374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2390162B-303A-46E6-BB6A-7E41C0AD7C84</gtr:id><gtr:title>Identification of phosphorylation sites in the COOH-terminal tail of the ?-opioid receptor.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/878ce0e4a7d078ff4be421ff84b917f5"><gtr:id>878ce0e4a7d078ff4be421ff84b917f5</gtr:id><gtr:otherNames>Chen YJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_15219_29_23106126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4E717E2-21D1-408B-A47D-E4C12B9C8275</gtr:id><gtr:title>Insights into the Plasmodium falciparum schizont phospho-proteome.</gtr:title><gtr:parentPublicationTitle>Microbes and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b16ce833706ec5ad157ee36c7cf4302e"><gtr:id>b16ce833706ec5ad157ee36c7cf4302e</gtr:id><gtr:otherNames>Lasonder E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1286-4579</gtr:issn><gtr:outcomeId>pm_15219_29_22569589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>250A4018-60DE-4145-817E-E95E6BEBDC5A</gtr:id><gtr:title>A unique protein phosphatase with kelch-like domains (PPKL) in Plasmodium modulates ookinete differentiation, motility and invasion.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/068ca74a42ae3f77d1c8f35065f0a4fd"><gtr:id>068ca74a42ae3f77d1c8f35065f0a4fd</gtr:id><gtr:otherNames>Guttery DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_15219_29_23028336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AF03F99-D375-47F8-AABC-B55CF139C8B9</gtr:id><gtr:title>A putative homologue of CDC20/CDH1 in the malaria parasite is essential for male gamete development.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/068ca74a42ae3f77d1c8f35065f0a4fd"><gtr:id>068ca74a42ae3f77d1c8f35065f0a4fd</gtr:id><gtr:otherNames>Guttery DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_15219_29_22383885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC236E14-EA27-4521-BE7D-1BD06C4201AA</gtr:id><gtr:title>Determination of GPCR Phosphorylation Status: Establishing a Phosphorylation Barcode.</gtr:title><gtr:parentPublicationTitle>Current protocols in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9735a4eaa72e7107ca56499f2542e04c"><gtr:id>9735a4eaa72e7107ca56499f2542e04c</gtr:id><gtr:otherNames>Prihandoko R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1934-8282</gtr:issn><gtr:outcomeId>56e02c9066a090.11816351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01265183-7B7F-4AA5-B306-F84639F16483</gtr:id><gtr:title>Reply to &amp;quot;Letter to the editor: 'Systems biology versus reductionism in cell physiology'&amp;quot;.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Cell physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d24c067c1642f29e57927e1e8018ba31"><gtr:id>d24c067c1642f29e57927e1e8018ba31</gtr:id><gtr:otherNames>Tobin AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0363-6143</gtr:issn><gtr:outcomeId>545cf423c92ae8.19422317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F59A8862-1933-411D-903D-E9AA647C03B4</gtr:id><gtr:title>Stimulus bias provides evidence for conformational constraints in the structure of a G protein-coupled receptor.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48b946c636eb9bcc7101db04bd519578"><gtr:id>48b946c636eb9bcc7101db04bd519578</gtr:id><gtr:otherNames>Gregory KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15219_29_22965232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C15C501-3617-471B-8542-88EFCF12847D</gtr:id><gtr:title>An Antibody Biosensor Establishes the Activation of the M1 Muscarinic Acetylcholine Receptor during Learning and Memory.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e0c9a4fe0722e2c4d5cb352e985443"><gtr:id>36e0c9a4fe0722e2c4d5cb352e985443</gtr:id><gtr:otherNames>Butcher AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56e01b5a6487c8.98955484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27768A4F-AD77-48DD-93D5-9BB8192FAD65</gtr:id><gtr:title>Design of Next-Generation G Protein-Coupled Receptor Drugs: Linking Novel Pharmacology and In Vivo Animal Models.</gtr:title><gtr:parentPublicationTitle>Annual review of pharmacology and toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/655e2cbad5f6560f048d3541e90b0d96"><gtr:id>655e2cbad5f6560f048d3541e90b0d96</gtr:id><gtr:otherNames>Bradley SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0362-1642</gtr:issn><gtr:outcomeId>56e01b84a59fa4.30434894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D11F732-A076-476E-8D89-9951B75D266F</gtr:id><gtr:title>Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmission.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3ac11caa0355e5c012fe846d46226b4"><gtr:id>c3ac11caa0355e5c012fe846d46226b4</gtr:id><gtr:otherNames>Kern S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545cf423f2b8c9.75200043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9DF0981-E3D3-4603-ACBB-09BF6979149F</gtr:id><gtr:title>The use of chemogenetic approaches to study the physiological roles of muscarinic acetylcholine receptors in the central nervous system.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/655e2cbad5f6560f048d3541e90b0d96"><gtr:id>655e2cbad5f6560f048d3541e90b0d96</gtr:id><gtr:otherNames>Bradley SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>5a2fcedc3952c8.66186634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05CA0155-D8D3-41B5-93E5-53BF623D0818</gtr:id><gtr:title>Phosphoproteomics reveals malaria parasite Protein Kinase G as a signalling hub regulating egress and invasion.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fbd39505663e1e77d042f13cfe7416c"><gtr:id>6fbd39505663e1e77d042f13cfe7416c</gtr:id><gtr:otherNames>Alam MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56e02d39f08af6.30265244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E36319F1-FA4F-4054-8B7D-0D37120BE185</gtr:id><gtr:title>Challenges of assigning protein kinases to in vivo phosphorylation events. Focus on &amp;quot;Use of LC-MS/MS and Bayes' theorem to identify protein kinases that phosphorylate aquaporin-2 at Ser256&amp;quot;.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Cell physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9735a4eaa72e7107ca56499f2542e04c"><gtr:id>9735a4eaa72e7107ca56499f2542e04c</gtr:id><gtr:otherNames>Prihandoko R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0363-6143</gtr:issn><gtr:outcomeId>545cf4249915d1.53995579</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_A600_1110</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>